Cencora, Inc. (COR) financials

Cencora, Inc. (COR) revenue, EBIT and EBITDA, earnings per share, free cash flow, margins, debt and shareholders equity — annual and quarterly history, charted from SEC filings. No account needed.

In fiscal 2025, Cencora, Inc. reported revenue of $321.33B, up 9.3% year over year, net income of $1.55B, diluted EPS of $7.96 and free cash flow of $3.21B.

Revenue (fiscal 2025)

$321.33B

Revenue growth (fiscal 2025)

9.3%

Net income (fiscal 2025)

$1.55B

Diluted EPS (fiscal 2025)

$7.96

Free cash flow (fiscal 2025)

$3.21B

Cencora, Inc. files with the U.S. Securities and Exchange Commission under CIK 0001140859, classified as Wholesale-Drugs, Proprietaries & Druggists' Sundries.

Explore annual and quarterly revenue, earnings, cash flow, margins, debt and equity from SEC filings.